Centene just posted a $1.09 billion net income for the second quarter.
That is a massive swing. Last year, the health insurer lost $253 million in the same period.
The numbers are stark: $2.19 per share this time around, up from a 50-cent loss. But the headline figure masks the real story. It isn’t just about making more money. It is about how Centene is aggressively shrinking its customer base to stabilize its margins.
Why Centene’s Health Benefits Ratio Is Dropping
Health insurers are currently wrestling with a simple problem: medical costs are eating their premiums.
Centene has been bleeding money on high healthcare expenses for a while now. Tuesday’s earnings report shows that bleeding has stopped. The health benefits ratio —the percentage of every premium dollar that goes to actual medical care—has dropped.
It was 93% last year. It is 89.6% now.
The industry hates anything over 90%. They want to see ratios in the mid-80s. Centene is getting there, but not purely by cutting care. They are doing it by changing who gets the care.
“Our second quarter results… represent meaningful milestones on our path to restoring profitability,” said CEO Sarah M. London. She cited a better “cost structure” as the driver.
What does that structure look like in practice?
The Shrinking Enrollment Factor
Centene’s total enrollment has tumbled.
It went from over 28 million members a year ago to nearly 25.9 million today.
That is a significant drop. Why? Because the company sold fewer plans through the Affordable Care Act marketplace under the Ambetter brand.
Marketplace enrollment at Centene fell to 3.5 million from 5.8 million.
This aligns with what analysts and Democrats in Congress have predicted. With Republicans in power and the Trump White House unwilling to extend enhanced tax credits for Obamacare buyers, premiums have skyrocketed.
A KFF analysis noted last fall that middle-income and low-income Americans would see “major out-of-pocket premium increases.”
Customers are feeling it. Premiums have doubled or even tripled.
People are leaving the plan. And when you stop selling policies to the sickest, most expensive members of the marketplace, your health benefits ratio improves.
It is a cold calculus. You reduce the pool of risky members to keep the ratio below 90%.
Commercial Plans Keep the Lights On
While the government-subsidized side shrinks, the commercial side is holding steady.
Centene reported a commercial health benefits ratio of just 79.2%.
That is well within the sweet spot the industry aims for.
The earnings report breaks down the other moving parts. The consolidated health benefits ratio benefited from:
- Lower marketplace HBR due to improved pricing.
- Rate increases in the Medicaid business to manage medical trends.
- Favorable resolution of programmatic elements in Medicare.
- Revenue increases that helped offset costs.
However, Medicare Advantage did face a headwind. The company had to increase its premium deficiency reserve (PDR) for 2025, something they didn’t do in 2026 due to a push toward profitability.
Still, the top-line revenue grew. Premium and service revenues hit $44.4 billion, up 4% from $42.5 billion last year.
The growth came from prescription drug plans (PDP), rate increases in Medicaid, and Marketplace risk adjustments for the 2025–2026 years.
State-directed payments also helped.
But the membership drop in Marketplace and Medicaid partially offset those gains.
Cutting Costs to Boost Guidance
The company is not just reacting. It is acting.
Centene executives are confident enough in these trends to raise their earnings guidance for the rest of 246.
How did they get there? They launched efforts to control costs, including worker buyouts.
They are streamlining. They are shedding membership. They are raising rates where possible.
The result is a company that is no longer losing money on its government-subsidized plans.
Centene is one of the nation’s largest providers of Obamacare plans. It is also a huge Medicaid provider for low-income Americans.
Now, it is becoming a company that relies less on the high-risk, high-cost segments of the marketplace and more on stable commercial ratios.
Is this sustainable?
Probably not if the political landscape shifts and subsidies return, flooding the marketplace with low-cost, high-risk members.
But for now? The costs are easing. The profits are back. And the shareholders are happy.
“We are excited by the positive momentum… focused on our goal of delivering industry-leading cost structure.”
The momentum is clear. The membership is smaller. The cost structure is leaner.
Whether that leads to better health outcomes remains to be seen. The financial outcomes, at least, look much better.
